SCHEMBL7594403

SCHEMBL7594403

CSc1ccccc1Cn1c(=O)n(CC(=O)O)c(=O)c2c(CNS(C)(=O)=O)c(-c3ccc(OCC(=O)N4CCNCC4)cc3)sc21

nearest known ligand 0.35

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
TPSAB1 Q15661 1/20 0.35
TPSD1 Q9BZJ3 1/20 0.35
TPSG1 Q9NRR2 1/20 0.35
ADORA2B P29275 13/20 0.34
ADORA2A P29274 12/20 0.34
ADORA1 P30542 3/20 0.34
GAA P10253 1/20 0.34
HTR1A P08908 1/20 0.33
HTR1D P28221 1/20 0.33
ADORA3 P0DMS8 2/20 0.32
ALDH1A1 P00352 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
GNRHR P30968 2/20 0.32
CPT2 P23786 1/20 0.32
CPT1A P50416 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7594402 0.90 KMT2A (0.32)
SCHEMBL7590037 0.88 GNRHR (0.34) ADORA2BADORA2AADORA1ADORA3GNRHR
SCHEMBL7595053 0.86 GNRHR (0.35) GNRHR
SCHEMBL7594784 0.86 GNRHR (0.35) GNRHR
SCHEMBL6704311 0.86 GNRHR (0.36) GNRHR
SCHEMBL7591544 0.86 GNRHR (0.43) GNRHR
SCHEMBL7593224 0.86 GNRHR (0.31) GNRHR
SCHEMBL7597312 0.84 MEN1 (0.36) ADORA2BADORA2AADORA3ALDH1A1SMN1; SMN2
SCHEMBL8189365 0.81 GNRHR (0.34) GNRHR
SCHEMBL7593479 0.81 ADORA2B (0.39) ADORA2BALDH1A1GNRHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0846119-B1 THIENOPYRIMIDINE DERIVATIVES, THEIR PRODUCTION AND USE AS ENDOTHELIN ANTAGONISTS TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2002-11-13 EP disclosed
US-6140325-A HAS ENDOTHELIN ANTAGONISTIC ACTION; FOR TREATING LIVER HYPOFUNCTION, ACUTE RENAL INSUFFICIENCY, CARDIAC INFARCTION OR LIVER INSUFFICIENCY, VASOCONSTRICTION TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2000-10-31 US disclosed